{
    "Trade/Device Name(s)": [
        "AU\u00ae Systems HbA1c (Hemoglobin) Test System"
    ],
    "Submitter Information": "Beckman Coulter, Inc.",
    "510(k) Number": "K120199",
    "Predicate Device Reference 510(k) Number(s)": [
        "K010748"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LCP",
        "JIT"
    ],
    "Summary Letter Date": "September 11, 2012",
    "Summary Letter Received Date": "September 13, 2012",
    "Submission Date": "January 20, 2012",
    "Regulation Number(s)": [
        "21 CFR 864.7470"
    ],
    "Regulation Name(s)": [
        "Glycosylated hemoglobin assay"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Hemoglobin A1c",
        "Total Hemoglobin"
    ],
    "Specimen Type(s)": [
        "Whole blood"
    ],
    "Specimen Container(s)": [
        "K2-EDTA tube",
        "K3-EDTA tube",
        "Lithium Heparin tube",
        "Sodium Heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "AU analyzer models (AU480, AU680, AU2700)"
    ],
    "Method(s)/Technology(ies)": [
        "Colorimetric",
        "Turbidimetric immunoinhibition"
    ],
    "Methodologies": [
        "Immunoinhibition assay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Calibrator"
    ],
    "Document Summary": "FDA 510(k) summary for Beckman Coulter AU\u00ae Systems HbA1c (Hemoglobin) Test System for quantitative determination of hemoglobin A1c in human whole blood",
    "Indications for Use Summary": "Quantitative determination of hemoglobin A1c in human whole blood to aid in long-term glucose control monitoring in patients with diabetes mellitus; results used for HbA1c/Total Hemoglobin ratio calculation only, not for individual diagnostic purposes",
    "fda_folder": "Hematology"
}